Cantourage Group SE (FRA:HIGH)

Market Cap	42.52M
Revenue (ttm)	1.95M
Net Income (ttm)	-95.53K
Shares Out	n/a
EPS (ttm)	n/a
PE Ratio	n/a
Forward PE	32.71
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	27
Open	3.250
Previous Close	3.250
Day's Range	3.210 - 3.250
52-Week Range	2.130 - 6.680
Beta	n/a
RSI	56.11
Earnings Date	Apr 30, 2026

About Cantourage Group SE

Cantourage Group SE operates as a medical cannabis company in Europe and internationally. The company offers cannabis flowers, extracts, dronabinol, tetrahydrocannabinol, and cannabidiol products. It exports its products. The company distributes its products through pharmacies, wholesalers, and partners. Cantourage Group SE was founded in 2019 and is headquartered in Berlin, Germany.

• Industry: Pharmaceutical Preparations
• Founded: 2019
• Employees: 7
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: HIGH

Financial Performance

In 2024, Cantourage Group SE's revenue was 2.20 million, an increase of 32.06% compared to the previous year's 1.66 million. Earnings were 79,293, an increase of 105.00%.